Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S2214-109X(21)00140-6 http://scihub22266oqcxt.onion/10.1016/S2214-109X(21)00140-6 33780663!7997645!33780663     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet+Glob+Health 2021 ; 9 (7): e1017-e1021 Nephropedia Template TP {{tp|p=33780663|t=2021. Operation Warp Speed: implications for global vaccine security |pdf=|usr=}}{{33780663}} gab.com Text Operation Warp Speed: implications for global vaccine security JO: Lancet Glob Health http://www.kidney.de/pget.php?&tw=1&pmid=33780663 #FOAvip Several global efforts are underway to develop COVID-19 vaccines, and interim analyses from phase 3 clinical testing have been announced by nine organisations: Pfizer, the Gamaleya Research Institute of Epidemiology and Microbiology, Moderna, AstraZeneca, Sinopharm Group, Sinovac Biotech, Johnson & Johnson, Novavax, and CanSino Biologics. The US programme known as Operation Warp Speed provided US$18 billion in funding for development of vaccines that were intended for US populations. Depending on safety and efficacy, vaccines can become available through mechanisms for emergency use, expanded access with informed consent, or full licensure. An important question is: how will these Operation Warp Speed vaccines be used for COVID-19 prevention in global health settings? We address some key questions that arise in the transition from US to global vaccine prevention efforts and from ethical and logistical issues to those that are relevant to global vaccine security, justice, equity, and diplomacy. Twit Text FOAVip Operation Warp Speed: implications for global vaccine security ????Lancet Glob Health http://www.kidney.de/pget.php?&tw=1&pmid=33780663 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33780663 #FOAvip English Wikipedia <ref>{{Cite pmid|33780663}}</ref> Operation Warp Speed: implications for global vaccine security #MMPMID33780663 ä Lancet Glob Health 2021[Jul]; 9 (7): e1017-e1021 PMID33780663show ga Several global efforts are underway to develop COVID-19 vaccines, and interim analyses from phase 3 clinical testing have been announced by nine organisations: Pfizer, the Gamaleya Research Institute of Epidemiology and Microbiology, Moderna, AstraZeneca, Sinopharm Group, Sinovac Biotech, Johnson & Johnson, Novavax, and CanSino Biologics. The US programme known as Operation Warp Speed provided US$18 billion in funding for development of vaccines that were intended for US populations. Depending on safety and efficacy, vaccines can become available through mechanisms for emergency use, expanded access with informed consent, or full licensure. An important question is: how will these Operation Warp Speed vaccines be used for COVID-19 prevention in global health settings? We address some key questions that arise in the transition from US to global vaccine prevention efforts and from ethical and logistical issues to those that are relevant to global vaccine security, justice, equity, and diplomacy. |*Global Health[MESH] |COVID-19 Vaccines/*supply & distribution[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Drug Development/*organization & administration[MESH] |Humans[MESH] |Randomized Controlled Trials as Topic[MESH]Operation Warp Speed: implications for global vaccine security (epmc).pdf DeepDyve Pubget Overpricing